The balance between protective and pathogenic immune responses in the TB-infected lung

Nature Immunology

Volumn 16, Issue 1, 2015, Pages 57-63

  Orme, Ian M ^a   Robinson, Richard T ^b   Cooper, Andrea M ^c  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; EPITOPE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 12P40; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; NITRIC OXIDE; PHENOLIC GLYCOLIPID; PROSTAGLANDIN E2; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; ANTIGEN RECOGNITION; APOPTOSIS; BACTERIAL GROWTH; CELLULAR IMMUNITY; DENDRITIC CELL; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LATENT TUBERCULOSIS; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG TUBERCULOSIS; LYMPH NODE; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PNEUMONIA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CD4+ T LYMPHOCYTE; DISEASE MODEL; IMMUNOLOGY; INNATE IMMUNITY; TRANSMISSION; TUBERCULOSIS;

ADAPTIVE IMMUNITY; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84924281504     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3048     Document Type: Review

References (82)

1. Trunz, B.B., Fine, P., Dye, C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367, 1173-1180 (2006).
2. Colditz, G.A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J. Am. Med. Assoc. 271, 698-702 (1994).
3. Cooper, A.M. Cell mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393-422 (2009).
4. Tameris, M.D. et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381, 1021-1028 (2013).
5. Gagneux, S. Host-pathogen coevolution in human tuberculosis. Phil. Trans. R. Soc. Lond. B 367, 850-859 (2012).
6. Ford, C.B. et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43, 482-486 (2011).
7. Lindestam Arlehamn, C.S. et al. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR+CCR+ Th1 Subset. PLoS Pathog. 9, e1003130 (2013).
8. Comas, I. et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42, 498-503 (2010).
9. Uplekar, S., Heym, B., Friocourt, V., Rougemont, J., Cole, S.T. Comparative genomics of Esx genes from clinical isolates of Mycobacterium tuberculosis provides evidence for gene conversion and epitope variation. Infect. Immun. 79, 4042-4049 (2011).
10. Ishikawa, E. et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 206, 2879-2888 (2009).
11. Werninghaus, K. et al. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcR-Syk-Card9-dependent innate immune activation. J. Exp. Med. 206, 89-97 (2009).
12. Schoenen, H. et al. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 184, 2756-2760 (2010).
13. Miyake, Y. et al. C-type lectin MCL is an FcR-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor. Immunity 38, 1050-1062 (2013).
14. Rao, V., Fujiwara, N., Porcelli, S., Glickman, M. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med. 201, 535-543 (2005).
15. Rao, V., Gao, F., Chen, B., Jacobs, W.J., Glickman, M. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J. Clin. Invest. 116, 1660-1667 (2006).
16. Dao, D.N. et al. Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog. 4, e1000081 (2008).
17. Havlir, D.V., Barnes, P. Tuberculosis patients with human immunodeficiency virus infection. N. Engl. J. Med. 340, 367-373 (1999).
18. Rich, A.R. The Pathogenesis of Tuberculosis (Charles C Thomas, 1944).
19. Gold, M.C. et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8, e1000407 (2010).
20. Rothchild, A.C., Jayaraman, P., Nunes-Alves, C., Behar, S.M. iNKT cell production of GM-CSF controls Mycobacterium tuberculosis. PLoS Pathog. 10, e1003805 (2014).
21. Chen, Z.W. Multifunctional immune responses of HMBPP-specific Vgamma2Vdelta2 T cells in M. tuberculosis and other infections. Cell. Mol. Immunol. 10, 58-64 (2013).
22. Azad, A.K., Sadee, W., Schlesinger, L.S. Innate immune gene polymorphisms in tuberculosis. Infect. Immun. 80, 3343-3359 (2012).
23. Filipe-Santos, O. et al. Inborn errors of IL-12/23-and IFN-mediated immunity: molecular, cellular, and clinical features. Semin. Immunol. 18, 347-361 (2006).
24. Filipe-Santos, O. et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J. Exp. Med. 203, 1745-1759 (2006).
25. Arcos, J. et al. Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection. J. Immunol. 187, 372-381 (2011).
26. Leemans, J.C. et al. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 166, 4604-4611 (2001).
27. Leemans, J.C. et al. Macrophages play a dual role during pulmonary tuberculosis in mice. J. Infect. Dis. 191, 65-74 (2005).
28. Cambier, C.J. et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 505, 218-222 (2014).
29. Martineau, A.R. et al. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Invest. 117, 1988-1994 (2007).
30. Casanova, J.L., Abel, L. The genetic theory of infectious diseases: a brief history and selected illustrations. Annu. Rev. Genomics Hum. Genet. 14, 215-243 (2013).
31. Vanden Driessche, K., Persson, A., Marais, B.J., Fink, P.J., Urdahl, K.B. Immune vulnerability of infants to tuberculosis. Clin. Dev. Immunol. 2013, 781320 (2013).
32. Zhang, M. et al. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J. Clin. Invest. 94, 2435-2442 (1994).
33. Chackerian, A.A., Alt, J., Perera, T., Dascher, C., Behar, S. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70, 4501-4509 (2002).
34. Reiley, W.W. et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in mediastinal lymph nodes. Proc. Natl. Acad. Sci. USA 105, 10961-10966 (2008).
35. Wolf, A.J. et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205, 105-115 (2008).
36. Orme, I.M. A new unifying theory of the pathogenesis of tuberculosis. Tuberculosis (Edinb.) 94, 8-14 (2014).
37. Ramakrishnan, L. Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 12, 352-366 (2012).
38. Schreiber, H.A. et al. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J. Clin. Invest. 121, 3902-3913 (2011).
39. Davis, J.M., Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49 (2009).
40. Egen, J.G. et al. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28, 271-284 (2008).
41. Egen, J.G. et al. Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34, 807-819 (2011).
42. Bhatt, K., Hickman, S.P., Salgame, P. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J. Immunol. 172, 2748-2751 (2004).
43. Khader, S.A. et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203, 1805-1815 (2006).
44. Robinson, R.T. et al. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12R1 isoform that enhances DC migration. J. Exp. Med. 207, 591-605 (2010).
45. Keeton, R. et al. Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis. J. Clin. Invest. 124, 1537-1551 (2014).
46. Samstein, M. et al. Essential yet limited role for CCR2+ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming. eLife 2, e01086 (2013).
47. Gallegos, A.M., Pamer, E., Glickman, M. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J. Exp. Med. 205, 2359-2368 (2008).
48. Khader, S.A. et al. IL-23 and IL-17 in establishment of protective pulmonary CD4+ T cell responses upon vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8, 369-377 (2007).
49. Gonzalez-Juarrero, M., Orme, I. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect. Immun. 69, 1127-1133 (2001).
50. Wolf, A.J. et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179, 2509-2519 (2007).
51. Sköld, M., Behar, S.M. Tuberculosis triggers a tissue dependent program of differentiation and acquisition of effector functions by circulating monocytes. J. Immunol. 181, 6349-6360 (2008).
52. Cooper, A.M., Adams, L.B., Dalton, D.K., Appelberg, R., Ehlers, S. IFN-and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 10, 221-226 (2002).
53. Nandi, B., Behar, S.M. Regulation of neutrophils by interferon-limits lung inflammation during tuberculosis infection. J. Exp. Med. 208, 2251-2262 (2011).
54. Desvignes, L., Ernst, J.D. Interferon-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31, 974-985 (2009).
55. Eum, S.Y. et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137, 122-128 (2010).
56. Berry, M.P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977 (2010).
57. Srivastava, S., Ernst, J.D. Cutting edge: direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis in vivo. J. Immunol. 191, 1016-1020 (2013).
58. Khader, S.A. et al. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J. Immunol. 183, 8004-8014 (2009).
59. Ulrichs, T. et al. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J. Pathol. 204, 217-228 (2004).
60. Kahnert, A. et al. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. J. Infect. Dis. 195, 46-54 (2007).
61. Slight, S.R. et al. CXCR5+ T helper cells mediate protective immunity against tuberculosis. J. Clin. Invest. 123, 712-726 (2013).
62. Khader, S.A. et al. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J. Immunol. 187, 5402-5407 (2011).
63. Sakai, S. et al. Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells. J. Immunol. 192, 2965-2969 (2014).
64. Arlehamn, C.L. et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J. Immunol. 193, 2931-2940 (2014).
65. Lin, P.L. et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med. 20, 75-79 (2014).
66. Scott-Browne, J. et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204, 2159-2169 (2007).
67. Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K., Urdahl, K.B. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 207, 1409-1420 (2010).
68. Shafiani, S. et al. Pathogen-specific Treg cells expand early during Mycobacterium tuberculosis infection but are later eliminated in response to interleukin-12. Immunity 38, 1261-1270 (2013).
69. Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522-531 (2007).
70. Ordway, D.J. et al. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells. Clin. Vaccine Immunol. 18, 1527-1535 (2011).
71. Antonelli, L.R. et al. Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120, 1674-1682 (2010).
72. Mayer-Barber, K.D. et al. Innate and adaptive interferons suppress IL-1 and IL-1 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023-1034 (2011).
73. Novikov, A. et al. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1 production in human macrophages. J. Immunol. 187, 2540-2547 (2011).
74. Mayer-Barber, K.D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99-103 (2014).
75. Chen, M. et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205, 2791-2801 (2008).
76. Divangahi, M., Desjardins, D., Nunes-Alves, C., Remold, H.G., Behar, S.M. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat. Immunol. 11, 751-758 (2010).
77. Divangahi, M. et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10, 899-906 (2009).
78. Tobin, D.M. et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717-730 (2010).
79. Tobin, D.M. et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148, 434-446 (2012).
80. Gomes, M.S., Florido, M., Pais, T.F., Appelberg, R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol. 162, 6734-6739 (1999).
81. Pearl, J.E. et al. Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection. Eur. J. Immunol. 42, 3267-3279 (2012).
82. Mishra, B.B. et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1. Nat. Immunol. 14, 52-60 (2013).